COMPLETED

Effectiveness of Adding Morphine to Intraosseous Vancomycin for Pain Control in Total Knee Arthroplasty

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Study investigators propose to investigate if a bony injection of pain medication during a knee replacement will help pain levels following primary knee replacement surgery. To investigate this, 86 patients will be enrolled. Half of the patients will receive a bony injection of antibiotics with morphine (pain medication) while the other half will receive a bony injection of antibiotics with placebo (no pain medication). Following surgery, patient pain levels and pain medication consumption will be measured. The injection is intraosseous meaning in the bone. The needle pierces the bone and the medication is injected into the bone. The site of injection is on the anterior (front) of the upper portion of the tibia. The medications are Vancomycin (antibiotic) and Morphine (pain medication) which are mixed in separate syringes and then injected. Intraosseous vancomycin is standard of care while intraosseous vancomycin with morphine is also standard of care, depending on operating surgeon.

Official Title

Effectiveness of Adding Morphine to Intraosseous Vancomycin for Pain Control in Total Knee Arthroplasty: A Double-Blind, Randomized Trial

Quick Facts

Study Start:2024-12-01
Study Completion:2025-06-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06716749

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 18-100 years old
  2. 2. Primary total knee arthroplasty
  3. 3. Participants must be able to consent for themselves
  4. 4. Capable and comfortable with text messaging
  1. 1. Non-primary total knee arthroplasty
  2. 2. Intraoperative or postoperative deviation from standard of care
  3. 3. Post-traumatic surgical indication
  4. 4. Post-infectious surgical indication
  5. 5. Chronic narcotic use or history of narcotic addiction
  6. 6. Allergy to vancomycin
  7. 7. Allergy to morphine
  8. 8. Inability to receive spinal anesthesia
  9. 9. Inability to receive intraoperative adductor canal block
  10. 10. Inability to provide informed consent for the study
  11. 11. Inability to speak English fluently

Contacts and Locations

Principal Investigator

Joseph T Moskal, MD
PRINCIPAL_INVESTIGATOR
Carilion Clinic

Study Locations (Sites)

Carilion Clinic
Roanoke, Virginia, 24014
United States

Collaborators and Investigators

Sponsor: Carilion Clinic

  • Joseph T Moskal, MD, PRINCIPAL_INVESTIGATOR, Carilion Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-01
Study Completion Date2025-06-02

Study Record Updates

Study Start Date2024-12-01
Study Completion Date2025-06-02

Terms related to this study

Additional Relevant MeSH Terms

  • Primary Total Knee Arthroplasty
  • Intraosseous Morphine Injection
  • Knee Osteoarthritis